These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 4380607)

  • 21. Optimization of sustained-release tablet formulations: a four-component mixture experiment.
    Hariharan M; Gupta V; Price JC
    Pharm Dev Technol; 1997 Nov; 2(4):365-71. PubMed ID: 9552465
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A randomised, placebo-controlled study comparing two formulations of dimenhydrinate with respect to efficacy in motion sickness and sedation.
    Seibel K; Schaffler K; Reitmeir P; Golly I
    Arzneimittelforschung; 2002; 52(7):529-36. PubMed ID: 12189776
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Controlled release formulation of tramadol hydrochloride using hydrophilic and hydrophobic matrix system.
    Tiwari SB; Murthy TK; Pai MR; Mehta PR; Chowdary PB
    AAPS PharmSciTech; 2003; 4(3):E31. PubMed ID: 14621963
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of superdisintegrants on efavirenz release from tablet formulations.
    Rajesh YV; Balasubramaniam J; Bindu K; Sridevi R; Swetha M; Rao VU
    Acta Pharm; 2010 Jun; 60(2):185-95. PubMed ID: 21134855
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Subcoating with Kollidon VA 64 as water barrier in a new combined native dextran/HPMC-cetyl alcohol controlled release tablet.
    Castellanos Gil E; Iraizoz Colarte A; Lara Sampedro JL; Bataille B
    Eur J Pharm Biopharm; 2008 May; 69(1):303-11. PubMed ID: 18053697
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correlation of dissolution and disintegration results for an immediate-release tablet.
    Nickerson B; Kong A; Gerst P; Kao S
    J Pharm Biomed Anal; 2018 Feb; 150():333-340. PubMed ID: 29287259
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of excipients, drugs, and osmotic agent in the inner core on the time-controlled disintegration of compression-coated ethylcellulose tablets.
    Lin SY; Lin KH; Li MJ
    J Pharm Sci; 2002 Sep; 91(9):2040-6. PubMed ID: 12210050
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Formulation development of carvedilol compression coated tablet.
    Shah R; Patel S; Patel H; Pandey S; Shah S; Shah D
    Pharm Dev Technol; 2013; 18(4):906-15. PubMed ID: 21797662
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gum Ghatti--a pharmaceutical excipient: development, evaluation and optimization of sustained release mucoadhesive matrix tablets of domperidone.
    Gurpreetarora ; Malik K; Rana V; Singh I
    Acta Pol Pharm; 2012; 69(4):725-37. PubMed ID: 22876617
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design and evaluation of matrix-based controlled release tablets of diclofenac sodium and chondroitin sulphate.
    Avachat A; Kotwal V
    AAPS PharmSciTech; 2007 Oct; 8(4):E88. PubMed ID: 18181548
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The use of natural and synthetic hydrophilic polymers in the formulation of metformin hydrochloride tablets with different profile release].
    Kołodziejczyk MK; Kołodziejska J; Zgoda MM
    Polim Med; 2012; 42(3-4):167-84. PubMed ID: 23457958
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sustained release of acetaminophen from a heterogeneous mixture of two hydrophilic non-ionic cellulose ether polymers.
    Ebube NK; Jones AB
    Int J Pharm; 2004 Mar; 272(1-2):19-27. PubMed ID: 15019065
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Simplified formulations with high drug loads for continuous twin-screw granulation.
    Meier R; Thommes M; Rasenack N; Krumme M; Moll KP; Kleinebudde P
    Int J Pharm; 2015 Dec; 496(1):12-23. PubMed ID: 26024821
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanistic Approach to Understanding the Influence of USP Apparatus I and II on Dissolution Kinetics of Tablets with Different Operating Release Mechanisms.
    Lu Z; Fassihi R
    AAPS PharmSciTech; 2017 Feb; 18(2):462-472. PubMed ID: 27106916
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The performance of HPMC matrix tablets using various agglomeration manufacturing processes.
    Košir D; Vrečer F
    Drug Dev Ind Pharm; 2017 Feb; 43(2):329-337. PubMed ID: 27739880
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Justification of disintegration testing beyond current FDA criteria using in vitro and in silico models.
    Uebbing L; Klumpp L; Webster GK; Löbenberg R
    Drug Des Devel Ther; 2017; 11():1163-1174. PubMed ID: 28442890
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rosin and rosin derivatives as hydrophobic matrix materials for controlled release of drugs.
    Pathak YV; Dorle AK
    Drug Des Deliv; 1990 Sep; 6(3):223-7. PubMed ID: 2076181
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Formulation Development and Optimization of Matrix Tablet of Tramadol Hydrochloride.
    Deb P; Singha J; Chanda I; Chakraborty P
    Recent Pat Drug Deliv Formul; 2017; 11(1):19-27. PubMed ID: 27712568
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hydroxypropyl methylcellulose based cephalexin extended release tablets: influence of tablet formulation, hardness and storage on in vitro release kinetics.
    Saravanan M; Sri Nataraj K; Ganesh KS
    Chem Pharm Bull (Tokyo); 2003 Aug; 51(8):978-83. PubMed ID: 12913240
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of honey locust (Gleditsia triacanthos Linn.) gum as sustaining material in tablet dosage forms.
    Uner M; Altinkurt T
    Farmaco; 2004 Jul; 59(7):567-73. PubMed ID: 15231434
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.